{"transactions":[{"id":1665405,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-31T21:56:01.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Schwartz in connection with his appointment as interim Chief Medical Officer of Cyclacel Pharmaceuticals, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the option vest in equal monthly installments beginning on February 29, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":2.28,"expiration_date":"2034-01-29","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-24-008862","document":"tm244773-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465924008862/tm244773-1_4seq1.xml","form_type":"4"}},{"id":1665404,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-31T21:56:01.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal monthly installments beginning on February 29, 2024, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Schwartz in connection with his appointment as interim Chief Medical Officer of Cyclacel Pharmaceuticals, Inc."}],"balance_after":15205,"source":{"system":"sec-edgar","filing":"0001104659-24-008862","document":"tm244773-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465924008862/tm244773-1_4seq1.xml","form_type":"4"}},{"id":1839963,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:55:19.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":42438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":42438,"derivative":{"exercise_price":0.5891,"exercise_date":"2024-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":42438},"source":{"system":"sec-edgar","filing":"0001104659-23-077650","document":"tm2320411-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077650/tm2320411-1_4seq1.xml","form_type":"4"}},{"id":1839962,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-03T20:55:19.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":40602,"source":{"system":"sec-edgar","filing":"0001104659-23-077650","document":"tm2320411-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077650/tm2320411-1_4seq1.xml","form_type":"4"}},{"id":2230366,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true}}],"security":"Stock Option(right to buy)","published_at":"2022-06-16T20:32:29.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer."}],"balance_after":45000,"derivative":{"exercise_price":0.679,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001140361-22-023308","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000114036122023308/form4.xml","form_type":"4"}},{"id":2230365,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-16T20:32:29.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":30919,"price":0.679,"value":20994.001,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the issuer's non-employee director compensation program, the reporting person has elected to receive this grant of shares in lieu of cash as payment of approximately 50% of such person's $42,000 annual retainer for service as a director."}],"balance_after":30919,"source":{"system":"sec-edgar","filing":"0001140361-22-023308","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000114036122023308/form4.xml","form_type":"4"}},{"id":2230353,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T20:11:49.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":31645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":31645,"derivative":{"exercise_price":1.11,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":31645},"source":{"system":"sec-edgar","filing":"0001104659-22-071895","document":"tm2218645-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071895/tm2218645-3_4seq1.xml","form_type":"4"}},{"id":2230352,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:11:49.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":15822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023."}],"balance_after":19383,"source":{"system":"sec-edgar","filing":"0001104659-22-071895","document":"tm2218645-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071895/tm2218645-3_4seq1.xml","form_type":"4"}},{"id":2573466,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-09-10T12:35:24.000Z","date":"2021-09-07","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":". The option vests as to 1/8th of the total number of shares on September 30, 2021 and as to 1/8th of the total number of shares at the end of each calendar quarter thereafter, provided that the Reporting Person continues to serve as a director of the Issuer."}],"balance_after":60000,"derivative":{"exercise_price":3.75,"expiration_date":"2031-09-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001140361-21-030894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000114036121030894/form4.xml","form_type":"4"}},{"id":2664329,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:07:23.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":2374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These options were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":7122,"derivative":{"exercise_price":6.69,"exercise_date":"2024-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":2374},"source":{"system":"sec-edgar","filing":"0001104659-21-082597","document":"tm2119990d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921082597/tm2119990d1_4.xml","form_type":"4"}},{"id":2664328,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:07:23.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":4748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These options were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":7122,"derivative":{"exercise_price":6.69,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":4748},"source":{"system":"sec-edgar","filing":"0001104659-21-082597","document":"tm2119990d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921082597/tm2119990d1_4.xml","form_type":"4"}},{"id":2664327,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T20:07:23.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":1187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reporting person received an award of 1,187 restricted stock units on June 15, 2021, which shall vest in three equal installments on June 15, 2022, June 15, 2023, and June 15, 2024."}],"balance_after":3561,"source":{"system":"sec-edgar","filing":"0001104659-21-082597","document":"tm2119990d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921082597/tm2119990d1_4.xml","form_type":"4"}},{"id":2664326,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T20:07:23.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":2374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 2,374 restricted stock units on June 15, 2021, which shall vest in full on June 15, 2022."}],"balance_after":3561,"source":{"system":"sec-edgar","filing":"0001104659-21-082597","document":"tm2119990d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921082597/tm2119990d1_4.xml","form_type":"4"}},{"id":2936432,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-21T21:48:12.000Z","date":"2020-12-17","kind":"grant","acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":5200,"derivative":{"exercise_price":4.13,"exercise_date":"2021-12-17","expiration_date":"2030-12-17","underlying":"Common Stock","underlying_shares":5200},"source":{"system":"sec-edgar","filing":"0001104659-20-138095","document":"tm2039008-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465920138095/tm2039008-2_4seq1.xml","form_type":"4"}},{"id":3309905,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":106500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":2.57,"expiration_date":"2024-01-22","underlying":"Common Stock","underlying_shares":106500},"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3309904,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":21376,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":2.51,"expiration_date":"2023-01-14","underlying":"Common Stock","underlying_shares":21376},"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3309903,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":12578,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":7.95,"expiration_date":"2022-02-01","underlying":"Common Stock","underlying_shares":12578},"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3309902,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":140000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":6.7,"expiration_date":"2021-01-24","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3309901,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":314050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":3.68,"expiration_date":"2029-01-15","underlying":"Common Stock","underlying_shares":314050},"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3309900,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":5.48,"expiration_date":"2028-07-23","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3309899,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":2.48,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3309898,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":107900,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2028-01-16","underlying":"Common Stock","underlying_shares":107900},"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3309897,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":260000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":0.95,"expiration_date":"2027-04-04","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3309896,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":130000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.53,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3309895,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":108000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.79,"expiration_date":"2026-01-19","underlying":"Common Stock","underlying_shares":108000},"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3309894,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":147000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.16,"expiration_date":"2025-01-20","underlying":"Common Stock","underlying_shares":147000},"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3309893,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-01-16T15:55:08.000Z","date":"2020-01-16","kind":"other","acquired":false,"shares":289838,"price":20,"value":5796760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 6, 2019, ArQule, Inc. (the \"Company\") entered into an Agreement and Plan of Merger (as amended, supplemented or otherwise modified from time to time, the \"Merger Agreement\") with Merck Sharpe & Dohme Corp. (\"MSD\") and Argon Merger Sub, Inc., a wholly-owned subsidiary of MSD (\"Merger Sub\"), pursuant to which MSD acquired the Company by a tender offer for all shares of Company common stock (the \"Offer\") and a subsequent merger (the \"Merger\"), each of which became effective on January 16, 2020. Pursuant to the Merger Agreement, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to $20.00 per share (the \"Offer Price\") and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), were cancelled and converted automatically into the right to receive the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-004714","document":"tm203607d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004714/tm203607d2_4.xml","form_type":"4"}},{"id":3334317,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-12-20T16:08:21.000Z","date":"2019-12-18","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.79,"exercise_date":"2019-01-19","expiration_date":"2026-01-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-19-074982","document":"tm1926797d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465919074982/tm1926797d1_4.xml","form_type":"4"}},{"id":3334316,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-12-20T16:08:21.000Z","date":"2019-12-18","kind":"exercise","acquired":false,"shares":64124,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.51,"exercise_date":"2017-01-14","expiration_date":"2023-01-14","underlying":"Common Stock","underlying_shares":64124},"source":{"system":"sec-edgar","filing":"0001104659-19-074982","document":"tm1926797d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465919074982/tm1926797d1_4.xml","form_type":"4"}},{"id":3334315,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-12-20T16:08:21.000Z","date":"2019-12-18","kind":"exercise","acquired":false,"shares":96922,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.95,"exercise_date":"2016-02-01","expiration_date":"2022-02-01","underlying":"Common Stock","underlying_shares":96922},"source":{"system":"sec-edgar","filing":"0001104659-19-074982","document":"tm1926797d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465919074982/tm1926797d1_4.xml","form_type":"4"}},{"id":3334314,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-12-20T16:08:21.000Z","date":"2019-12-18","kind":"exercise","acquired":false,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.42,"exercise_date":"2014-01-21","expiration_date":"2020-01-21","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001104659-19-074982","document":"tm1926797d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465919074982/tm1926797d1_4.xml","form_type":"4"}},{"id":3334313,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-20T16:08:21.000Z","date":"2019-12-18","kind":"tax_withholding","acquired":false,"shares":178495,"price":20.11,"value":3589534.45,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person satisfied the exercise price and applicable tax withholding by electing to have the Company retain shares otherwise issuable upon exercise of the options. No shares were sold into the market as part of this transaction, and the Reporting Person continues to hold the net shares realized from the option exercise."}],"balance_after":289838,"source":{"system":"sec-edgar","filing":"0001104659-19-074982","document":"tm1926797d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465919074982/tm1926797d1_4.xml","form_type":"4"}},{"id":3334312,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-20T16:08:21.000Z","date":"2019-12-18","kind":"exercise","acquired":true,"shares":100000,"price":1.79,"value":179000.0,"ownership":{"direct":true},"balance_after":468333,"source":{"system":"sec-edgar","filing":"0001104659-19-074982","document":"tm1926797d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465919074982/tm1926797d1_4.xml","form_type":"4"}},{"id":3334311,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-20T16:08:21.000Z","date":"2019-12-18","kind":"exercise","acquired":true,"shares":64124,"price":2.51,"value":160951.24,"ownership":{"direct":true},"balance_after":368333,"source":{"system":"sec-edgar","filing":"0001104659-19-074982","document":"tm1926797d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465919074982/tm1926797d1_4.xml","form_type":"4"}},{"id":3334310,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-20T16:08:21.000Z","date":"2019-12-18","kind":"exercise","acquired":true,"shares":96922,"price":7.95,"value":770529.9,"ownership":{"direct":true},"balance_after":304209,"source":{"system":"sec-edgar","filing":"0001104659-19-074982","document":"tm1926797d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465919074982/tm1926797d1_4.xml","form_type":"4"}},{"id":3334309,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-20T16:08:21.000Z","date":"2019-12-18","kind":"exercise","acquired":true,"shares":90000,"price":3.42,"value":307800.0,"ownership":{"direct":true},"balance_after":207287,"source":{"system":"sec-edgar","filing":"0001104659-19-074982","document":"tm1926797d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465919074982/tm1926797d1_4.xml","form_type":"4"}},{"id":3596075,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options","published_at":"2019-03-14T16:35:59.000Z","date":"2019-03-12","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned shares with respect to a performance stock option granted on 4/4/2017 that contained performance requirements. The issuer's Board of Directors and Compensation, Nominating and Governance Committee certified as to the performance-goal attainment on 03/12/2019.  The shares remain subject to time-based vesting in 12 quarterly installments from 4/4/2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents earned shares with respect to a performance stock option granted on 4/4/2017 that contained performance requirements. The issuer's Board of Directors and Compensation, Nominating and Governance Committee certified as to the performance-goal attainment on 03/12/2019.  The shares remain subject to time-based vesting in 12 quarterly installments from 4/4/2017."}],"balance_after":130000,"derivative":{"exercise_price":0.95,"expiration_date":"2027-04-03","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001019695-19-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969519000005/primary_doc.xml","form_type":"4"}},{"id":3693756,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options","published_at":"2019-01-17T14:18:41.000Z","date":"2019-01-15","kind":"grant","acquired":true,"shares":314050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal annual installments beginning on January 15, 2020."}],"balance_after":314050,"derivative":{"exercise_price":3.68,"expiration_date":"2029-01-15","underlying":"Common Stock","underlying_shares":314050},"source":{"system":"sec-edgar","filing":"0001019695-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969519000003/primary_doc.xml","form_type":"4"}},{"id":3861686,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options","published_at":"2018-07-25T15:55:38.000Z","date":"2018-07-23","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal annual installments beginning on July 23, 2019."}],"balance_after":65000,"derivative":{"exercise_price":5.48,"expiration_date":"2028-07-23","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001144204-18-039883","document":"tv499267_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000114420418039883/tv499267_4.xml","form_type":"4"}},{"id":3894506,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-06-14T09:27:17.000Z","date":"2018-06-13","kind":"exercise","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.62,"exercise_date":"2012-07-14","expiration_date":"2018-07-14","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001019695-18-000023","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969518000023/primary_doc.xml","form_type":"4"}},{"id":3894505,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-14T09:27:17.000Z","date":"2018-06-13","kind":"tax_withholding","acquired":false,"shares":148569,"price":5.18,"value":769587.42,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person exercised options that were scheduled to expire in July, 2018 during a trading blackout period. The Reporting Person satisfied the exercise price and applicable tax withholding by electing to have the Company retain shares otherwise issuable upon exercise of the options. No shares were sold into the market as part of this transaction, and the Reporting Person continues to hold the net shares realized from the option exercise."}],"balance_after":97169,"source":{"system":"sec-edgar","filing":"0001019695-18-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969518000023/primary_doc.xml","form_type":"4"}},{"id":3894504,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-14T09:27:17.000Z","date":"2018-06-13","kind":"exercise","acquired":true,"shares":200000,"price":3.62,"value":724000.0,"ownership":{"direct":true},"balance_after":245738,"source":{"system":"sec-edgar","filing":"0001019695-18-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969518000023/primary_doc.xml","form_type":"4"}},{"id":3937563,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options","published_at":"2018-05-11T16:01:06.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal annual installments beginning on May 8, 2019."}],"balance_after":40000,"derivative":{"exercise_price":2.48,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001019695-18-000016","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969518000016/primary_doc.xml","form_type":"4"}},{"id":3939562,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options","published_at":"2018-05-10T14:37:20.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":107900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Granted on January 16, 2018, subject to stockholder approval received on May 8, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in four equal annual installments beginning on January 16, 2019."}],"balance_after":107900,"derivative":{"exercise_price":1.75,"expiration_date":"2028-01-16","underlying":"Common Stock","underlying_shares":107900},"source":{"system":"sec-edgar","filing":"0001019695-18-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969518000010/primary_doc.xml","form_type":"4"}},{"id":4488787,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options","published_at":"2017-01-18T16:23:09.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal annual installments beginning on January 17, 2018."}],"balance_after":130000,"derivative":{"exercise_price":1.53,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001019695-17-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969517000006/primary_doc.xml","form_type":"4"}},{"id":4488786,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-01-18T16:23:09.000Z","date":"2017-01-14","kind":"tax_withholding","acquired":false,"shares":2847,"price":1.58,"value":4498.26,"ownership":{"direct":true},"balance_after":45738,"source":{"system":"sec-edgar","filing":"0001019695-17-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969517000006/primary_doc.xml","form_type":"4"}}]}